East Tennessee State University

Digital Commons @ East Tennessee State University
ETSU Faculty Works

Faculty Works

3-11-2011

Fungal Recognition Enhances Mannose Receptor Shedding
Through Dectin-1 Engagement
Umut Gazi
University of Nottingham

Marcela Rosas
Cardiff University School of Medicine

Sonali Singh
University of Nottingham

Sigrid Heinsbroek
Universiteit van Amsterdam

Imran Haq
University of Nottingham

See next page for additional authors

Follow this and additional works at: https://dc.etsu.edu/etsu-works

Citation Information
Gazi, Umut; Rosas, Marcela; Singh, Sonali; Heinsbroek, Sigrid; Haq, Imran; Johnson, Simon; Brown, Gordon
D.; Williams, David L.; Taylor, Philip R.; and Martinez-Pomares, Luisa. 2011. Fungal Recognition Enhances
Mannose Receptor Shedding Through Dectin-1 Engagement. Journal of Biological Chemistry.
Vol.286(10). 7822-7829. https://doi.org/10.1074/jbc.M110.185025 PMID: 21205820 ISSN: 0021-9258

This Article is brought to you for free and open access by the Faculty Works at Digital Commons @ East Tennessee
State University. It has been accepted for inclusion in ETSU Faculty Works by an authorized administrator of Digital
Commons @ East Tennessee State University. For more information, please contact digilib@etsu.edu.

Fungal Recognition Enhances Mannose Receptor Shedding Through Dectin-1
Engagement
Copyright Statement
© 2011 by The American Society for Biochemistry and Molecular Biology, Inc.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

Creator(s)
Umut Gazi, Marcela Rosas, Sonali Singh, Sigrid Heinsbroek, Imran Haq, Simon Johnson, Gordon D. Brown,
David L. Williams, Philip R. Taylor, and Luisa Martinez-Pomares

This article is available at Digital Commons @ East Tennessee State University: https://dc.etsu.edu/etsu-works/
16349

Author’s Choice

THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 286, NO. 10, pp. 7822–7829, March 11, 2011
© 2011 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.

Fungal Recognition Enhances Mannose Receptor Shedding
through Dectin-1 Engagement*
Received for publication, September 15, 2010, and in revised form, December 21, 2010 Published, JBC Papers in Press, January 4, 2011, DOI 10.1074/jbc.M110.185025

Umut Gazi‡§1, Marcela Rosas¶, Sonali Singh‡§, Sigrid Heinsbroek储, Imran Haq§**, Simon Johnson§**,
Gordon D. Brown‡‡, David L. Williams§§, Philip R. Taylor¶, and Luisa Martinez-Pomares‡§2
From the ‡School of Molecular Medical Sciences, **Division of Therapeutics and Molecular Medicine, and §Respiratory Biomedical
Research Unit, Queen’s Medical Centre, University of Nottingham, Nottingham NG7 2UH, United Kingdom, the ¶Department of
Infection, Immunity, and Biochemistry, Cardiff University School of Medicine, Cardiff CF14 4XN, United Kingdom, the 储Department
of Gastroenterology, Academic Medical Centre, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands, the ‡‡Aberdeen
Fungal Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB24 3FX, Scotland, United Kingdom, and the
§§
Department of Surgery, Quillen College of Medicine, East Tennessee State University, Johnson City, Tennessee 37614
The mannose receptor (MR) is an endocytic type I membrane
molecule with a broad ligand specificity that is involved in both
hemostasis and pathogen recognition. Membrane-anchored
MR is cleaved by a metalloproteinase into functional soluble MR
(sMR) composed of the extracellular domains of intact MR.
Although sMR production was initially considered a constitutive process, enhanced MR shedding has been observed in
response to the fungal pathogen Pneumocystis carinii. In this
work, we have investigated the mechanism mediating enhanced
MR shedding in response to fungi. We show that other fungal
species, including Candida albicans and Aspergillus fumigatus,
together with zymosan, a preparation of the cell wall of Saccharomyces cerevisiae, mimic the effect of P. carinii on sMR production and that this effect takes place mainly through ␤-glucan
recognition. Additionally, we demonstrate that MR cleavage in
response to C. albicans and bioactive particulate ␤-glucan
requires expression of dectin-1. Our data, obtained using specific inhibitors, are consistent with the canonical Syk-mediated
pathway triggered by dectin-1 being mainly responsible for
inducing MR shedding, with Raf-1 being partially involved. As
in the case of steady-state conditions, MR shedding in response
to C. albicans and ␤-glucan particles requires metalloprotease
activity. The induction of MR shedding by dectin-1 has clear
implications for the role of MR in fungal recognition, as sMR
was previously shown to retain the ability to bind fungal pathogens and can interact with numerous host molecules, including
lysosomal hydrolases. Thus, MR cleavage could also impact on
the magnitude of inflammation during fungal infection.

The mannose receptor (MR)3 is an endocytic receptor with
three distinct types of domains at its extracellular region, a sin-
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gle transmembrane region, and a cytoplasmic tail. The extracellular region mediates binding of a wide range of ligands; the
N-terminal cysteine-rich domain is involved in sulfated sugar
recognition in a Ca2⫹-independent manner; the fibronectin
type II domain binds collagen types I–IV; and the eight C-type
lectin-like domains are responsible for Ca2⫹-dependent binding to sugars terminating in mannose, fucose, or N-acetylglucosamine (1). This broad range of ligand binding, including
endogenous antigens (such as lysosomal enzymes released into
the extracellular milieu during inflammation, as well as thyroglobulin) and microbial antigens (Candida albicans, Leishmania, Mycobacterium tuberculosis, HIV, and Pneumocystis carinii), enables MR to participate in a wide range of processes,
including hemostatic clearance, pathogen recognition, and cell
migration (1, 2).
In addition to the cell-associated form (cMR), a soluble form
of MR (sMR) has been detected previously in the supernatants
from human dendritic cells and mouse macrophages (M) and
in mouse and human sera (3– 6). sMR comprises the extracellular region of the receptor and is produced as a result of proteolytic cleavage of cMR by a metalloprotease (4). sMR has been
suggested to play an important role in transferring mannosylated antigens to a subset of macrophages present in secondary
lymphoid organs (7) and also in assisting pathogens to escape
the immune response (8). Although initial studies indicated
that MR shedding was a constitutive process, as the levels of
sMR correlated with the amount of cMR present in the cells
(5), Fraser et al. (8) observed that P. carinii enhanced sMR
production.
␤-Glucan is considered to be a major fungus-associated
molecular pattern composing nearly 50% of the cell wall.
␤-Glucan consists of long polymers of ␤(1,3)-linked glucose
with ␤(1,6)-linked branches. These polysaccharides are highly
immunogenic, and in the fungal cell wall, they are mostly
masked underneath a layer of mannosylated proteins. In certain
fungal species such as C. albicans conidia and Aspergillus
fumigatus maturing conidia, ␤-glucan surface expression can
be detected also on restricted regions such as bud scars (9, 10).
based activation motif; TLR, Toll-like receptor; KO, knock-out; thio-M,
thioglycolate-elicited M; HK, heat-killed; MMP, matrix metalloproteinase;
Pam3, (S)-[2,3-Bis(palmitoyloxy)-(2-RS)-propyl]-N-palmitoyl-(R)-Cys-(S)-Ser(S)-Lys4-OH䡠3HCl.
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Dectin-1 does not bind ␤(1,3/1,4)-glucans to any appreciable
extent (11).
Dectin-1 is a non-classical C-type lectin-like receptor with a
type II transmembrane protein topology. The extracellular
region of dectin-1 is composed of a single C-type lectin-like
domain responsible for Ca2⫹-independent ␤-glucan binding
and a short stalk, which is followed by a transmembrane
domain and a cytoplasmic tail that contains an immunoreceptor tyrosine-based activation motif (ITAM)-like motif that
mediates intracellular signaling (10). In mice, there are two isoforms as a result of alternative splicing: full-length dectin-1A
and “stalkless” dectin-1B (12).
Dectin-1 was shown to recognize several fungal species,
including P. carinii, C. albicans, Coccidioides posadasii, and
A. fumigatus (10). Upon engagement, dectin-1 triggers intracellular signaling mediating a variety of cell responses, including phagocytosis, endocytosis, oxidative burst, activation and
regulation of phospholipase A2 and cyclooxygenase-2, and production of various cytokines and chemokines (e.g. TNF, IL-2,
IL-10, IL-6, and IL-23) (10, 13).
Dectin-1 can signal through both Syk-dependent and Sykindependent pathways. The Syk-dependent pathway involves
phosphorylation of the cytoplasmic ITAM motif by Src kinases,
allowing the recruitment and activation of Syk kinase (14, 15).
The Syk-independent pathway is poorly characterized, and the
only identified kinase involved is Raf-1 (16).
Dectin-1-mediated signaling can act independently (e.g. IL-2,
IL-10, and reactive oxygen species) as well as in cooperation
with the Toll-like receptor (TLR) pathway (e.g. TNF-␣ and
IL-12) (10, 13). MyD88 and Syk (17), Raf-1 kinase (16), and
CARD9 (18) were found to be required for this collaborative
response.
In this study, we investigated if MR shedding could be upregulated by other fungi in addition to P. carinii. Our results
demonstrate that non-opsonic recognition of zymosan (a preparation of the cell wall of Saccharomyces cerevisiae), C. albicans,
and A. fumigatus by M leads to enhanced sMR production.
Using purified soluble and particulate ␤-glucan and knock-out
(KO) macrophages, we demonstrate that C. albicans-induced
shedding is caused by the recognition of ␤-glucan on the fungal
cell wall, that ␤-glucan binding is sufficient to induce shedding,
and that this process requires dectin-1 expression, with inhibition studies supporting the involvement of Syk- and PI3K-dependent pathways and the need for metalloproteinase activity.
Additionally, we observed a major effect of actin polymerization inhibitors on MR expression. Our results unveil a novel
outcome for dectin-1 engagement, the rapid activation of metalloproteases leading to MR cleavage, which could potentially
modulate the contribution of MR to fungal recognition.

EXPERIMENTAL PROCEDURES
Animals—WT C57BL/6 and BALB/c mice were supplied by
Charles River, and MR-KO mice were breed at the Biomedical
Services Unit of the University of Nottingham. Animals were
handled according to institutional and UK Home Office guidelines and were kept under specific pathogen-free conditions.
They were used at 7–10 weeks of age. Dectin-1-KO mice and
their controls were on a 129S6/SvEv genetic background and
MARCH 11, 2011 • VOLUME 286 • NUMBER 10

were maintained in accordance with institutional guidelines at
Cardiff University School of Medicine.
Cells—Thioglycolate-elicited M (thio-M) were obtained
by intraperitoneal injection of 4% (w/v) brewers’ thioglycolate
broth (Sigma) 4 days before harvest. Mice were killed, and the
peritoneal cavities were rinsed with PBS (Sigma) containing 5
mM EDTA. M were cultured overnight on 6-well tissue culture plates (1.25 ⫻ 106 cells/well; BD Biosciences) in RPMI 1640
medium (Sigma) supplemented with R-10 medium (10% heatinactivated (56 °C at 30 min) FBS (Sigma), 2 mM glutamine
(Sigma), 100 units/ml penicillin, 100 g/ml streptomycin
(Sigma), and 10 mM Hepes (Invitrogen)) and washed three
times with PBS prior use.
Experimental Conditions—Thio-M were treated with
zymosan (Invitrogen), particulate ␤-glucan, fixed A. fumigatus,
heat-killed (HK) and fixed C. albicans (ATCC 18804), curdlan
(Wako), and fixed Staphylococcus aureus (RN6390B strain,
kindly contributed by Alan Cockayne, University of Nottingham) at concentrations of 50 particles/cell and/or Pam3-CysSer-Lys4 (Alexis Biochemicals) in serum-free Opti-MEM
medium (Invitrogen) supplemented with 2 mM glutamine, 100
units/ml penicillin, and 100 g/ml streptomycin for 3 h at 37 °C
and 5% CO2. Before treatment with formaldehyde-fixed stimuli, free aldehyde groups were quenched by incubating with 0.1
M glycine in PBS, followed by three washes with PBS.
For inhibition assays, thio-M were preincubated with
␤-glucan phosphate, mannan (Sigma), Syk kinase inhibitor IV,
wortmannin, Akt inhibitor VI, Raf-1 kinase inhibitor I,
GM6001 (N-[(2R)-2(hydroxamidocarbonylmethyl)-4-methylpentanoyl]-L-tryptophan methylamide, a potent broad-spectrum hydroxamic acid inhibitor of matrix metalloproteases), a
control for GM6001 (N-t-butoxycarbonyl-L-leucyl-L-tryptophan methylamide), cytochalasin D, latrunculin A (all from
Calbiochem) or bafilomycin or chloroquine (Sigma) at the indicated concentrations for 1 h before treatment and were present
during the incubation with the stimuli.
Collection of Culture Media and Preparation of Cell Lysates—
Cell culture supernatants were collected after the addition of
1⫻ protease inhibitors (Roche Applied Science), 10 mM EDTA,
and 1 mg/ml BSA (Sigma). Following PBS washes, M were
lysed using lysis buffer (2% Triton X-100, 10 mM Tris-HCl (pH
8), 150 mM NaCl, 2 mM NaN3, and 10 mM EDTA) plus protease
inhibitors for 45 min at 4 °C. The cell lysates and the culture
media were centrifuged at 2000 rpm for 5 min at 4 °C and at
13,000 rpm for 30 min at 4 °C using a benchtop centrifuge. The
cleared cell lysates and supernatants were stored at ⫺20 °C.
Protein concentration was determined using the BCA protein
assay kit (Perbio) following the manufacturer’s protocol.
Western Blotting—Cell lysate (3 g of protein) and the corresponding fraction of non-concentrated culture supernatant
were electrophoresed under nonreducing conditions on a 6%
SDS-polyacrylamide gel, and proteins were transferred overnight to Hybond-C extra nitrocellulose membrane (GE
Healthcare). After a 1-h incubation in blocking buffer (5%
nonfat milk in PBS and 0.1% Tween 20), MR and CD44 were
visualized using rat anti-MR mAb (clone 5D3, prepared in
house) and rat anti-CD44 mAb (clone KM201, Abcam) respectively, in combination with HRP-conjugated anti-rat IgG
JOURNAL OF BIOLOGICAL CHEMISTRY
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(Chemicon) and enhanced chemiluminescence reagent (Amersham Biosciences).
Flow Cytometry Analysis—Thio-M were plated for 2 h at
37 °C and 5% CO2 on bacteriological plastic in Opti-MEM with
GlutaMAX containing 100 units/ml penicillin and 100 g/ml
streptomycin. After 2 h, Opti-MEM was replaced with R-10
medium; cells were maintained at 37 °C and 5% CO2 overnight;
and M were selected by washing three times with cold PBS.
M were collected by scraping in the presence of non-enzymatic cell dissociation buffer (Sigma), washed with FACS block
buffer (5% heat-inactivated rabbit serum, 0.5% BSA, 2 mM
NaN3, and 5 mM EDTA in PBS), and incubated in FACS block
buffer containing 2.4G2 (10 g/ml) for 30 min at 4 °C. After
blocking, M were incubated with Alexa 488-labeled anti-MR
Ab (clone 5D3, BioLegend) or FITC-labeled anti-dectin-1 Ab
(clone 2A11, AbD Serotec) for 60 min at 4 °C. After staining,
cells were washed three times with FACS wash buffer (0.5%
BSA, 2 mM NaN3, and 5 mM EDTA in PBS) and fixed in 1%
paraformaldehyde in PBS. Isotype-matched Abs were used as
controls. Labeling was analyzed using a Beckman Coulter Epics
Altra system.
Real-time Quantitative PCR—RNA was extracted and purified using an RNeasy mini kit (Qiagen). DNase digestion was
performed using an RNase-free DNase set (Qiagen), and 500 –
1000 ng of total RNA was used in the reverse transcription
reactions. Quantitative PCR was performed using Brilliant
SYBR Green QPCR Master Mix (Stratagene) according to the
manufacturer’s instructions in an Mx3005P instrument (Stratagene). MxPro-Mx3005P software was used to analyze results.
The primers used were as follows: HPRT, 5⬘-GTAATGATCAGTCAACGGGGGAC-3⬘ (forward) and CCAGCAAGCTTGCAACCTTAACCA-3⬘ (reverse); MMP-9, 5⬘-CAGAGGTAACCCACGTCAGC-3⬘ (forward) and 5⬘-GGGATCCACCTTCTGAGACTT-3⬘ (reverse); and MMP-8, 5⬘-CTTTCAACCAGGCCAAGG-3⬘ (forward) and 5⬘-GAGCAGCCACGAGAAATAGG-3⬘ (reverse).
Cytokine Assays—The levels of TNF-␣ and KC (CXCL1)
were determined using the mouse TNF-␣ DuoSet and mouse
CXCL1/KC DuoSet (R&D Systems), respectively.

RESULTS
MR Shedding Is Promoted by Non-opsonic Recognition of
Fungal Particles—To investigate if stimulation of M with
other fungal particles in addition to P. carinii (8) could promote
MR shedding, thio-M were treated with zymosan, a S. cerevisiae-derived bioparticle, under serum-free conditions for 1.5
and 3 h. After treatment, cell culture supernatants and cell
lysates were analyzed for sMR and cMR levels, respectively, by
Western blotting. As shown in Fig. 1A, sMR could be detected
in the supernatants of zymosan-treated cells at 1.5 h post-treatment with levels increasing at 3 h. No sMR could be detected in
the supernatants of untreated cells under these conditions. In
support of a more general effect of fungi in enhancing the production of sMR, supernatants collected from M treated with
fixed A. fumigatus and fixed and HK C. albicans under serumfree conditions for 3 h also contained increased levels of sMR
(Fig. 1B). This effect appears to be pathogen-specific, as
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FIGURE 1. MR shedding is induced by zymosan, C. albicans, and
A. fumigatus and requires ␤-glucan recognition. Thio-M were incubated
with zymosan (50 particles/cell; Z-50) for 1.5 and 3 h at 37 °C (A) or fixed
A. fumigatus (A. f.) and fixed or HK C. albicans (50 particles/cell) for 3 h at 37 °C
in serum-free medium (B). cMR and sMR levels were assessed in cell lysates
and supernatants, respectively, by Western blot analysis as described under
“Experimental Procedures.” All fungal particles induced MR shedding (A and
B). MR shedding in response to HK C. albicans could be inhibited by soluble
␤-glucan phosphate (␤-Gluc; 1 mg/ml) but not by mannan (Man; 1 mg/ml) (C).
Data are representative of three independent experiments. Unt, untreated.

increased MR shedding was not evident when fixed S. aureus
was used (data not shown).
The method of fungal processing appeared to have an effect
on the level of sMR production, as HK C. albicans consistently
induced more MR shedding than the fixed fungal particles. As
the ␤-glucan component of the cell wall is thought to become
more exposed during heat inactivation, we hypothesized that
enhanced ␤-glucan exposure could be responsible for the differences observed between HK and fixed fungi and that the
recognition of ␤-glucan in the fungal cell wall could be responsible for their effect on MR cleavage. We investigated this possibility by performing the treatment with HK C. albicans in the
presence of soluble glucan phosphate. Fig. 1C shows that glucan
phosphate (but not mannan) treatment considerably blocked
sMR production, which suggests that fungus-induced MR
shedding is mediated mainly through the recognition of the
␤-glucan component of the cell wall. These results also demonVOLUME 286 • NUMBER 10 • MARCH 11, 2011
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FIGURE 2. ␤-Glucan treatment induces sMR production through dectin-1
engagement independently of the mouse strain and does not promote
CD44 shedding. Sex- and age-matched WT and dectin-1-KO thio-M were
treated with ␤-glucan particles (50 particles/cell) in the presence and absence
of 1 mg/ml glucan phosphate (␤-Gluc) or 1 mg/ml mannan (Man) (A). Sex- and
age-matched WT and dectin-1-KO thio-M were treated with HK C. albicans
(50 particles/cell) (B). Analysis of cell lysates and culture supernatants by
Western blotting demonstrated dectin-1-mediated enhanced sMR production in response to particulate ␤-glucan that could be inhibited by soluble
␤-glucan but not by mannan (A). Similarly, sMR production in response to HK
C. albicans was reduced in dectin-1-deficient cells (B). Both C57BL/6 and
BALB/c M were capable of shedding MR in response to particulate ␤-glucan
(C), despite the different levels of surface dectin-1 expression in each strain
(D). CD44 could be detected in cell lysates but not in supernatants from ␤-glucan-treated WT M, whereas cMR and sMR were detected in cell lysates and
supernatants, respectively (E). No signal could be detected in supernatants
from MR-KO cells treated with ␤-glucan (F). Data are representative of two or
three independent experiments (A–D and F). Unt, untreated.

strate that the recognition of soluble ␤-glucan or mannan per se
is insufficient for inducing sMR production.
␤-Glucan Particles Induce MR Shedding through Dectin-1
Engagement—To investigate if the recognition of particulate
␤-glucan is sufficient to induce MR cleavage, we analyzed sMR
production by thio-M in response to purified ␤-glucan particles. The ␤-glucan particles used in these experiments were
isolated from S. cerevisiae and consist of ␤(1–3)-linked glucose
with a limited number of ␤(1– 6)-linkages. Particulate ␤-glucan
enhanced MR shedding when used at a particle/cell ratio similar to that used in the case of zymosan, C. albicans, and
A. fumigatus, and pretreatment with soluble glucan phosphate
demonstrated that this effect was not mediated by any contaminant present in the preparation of particulate ␤-glucan (Fig. 2A).
MARCH 11, 2011 • VOLUME 286 • NUMBER 10

Using dectin-1-KO thio-M, we determined that dectin-1, the
major ␤-glucan receptor, is essential for the induction of MR
shedding in response to particulate ␤-glucan, as no enhanced
sMR production was observed in response to particulate ␤-glucan when these cells were tested (Fig. 2A). HK C. albicans-induced sMR production was also reduced in dectin-1-KO cells,
although to a lesser extent (Fig. 2B).
When thio-M from C57BL/6 and BALB/c mice were compared, similar levels of sMR production in response to ␤-glucan
were observed (Fig. 2C), indicating that the presence of different alternatively spliced isoforms of dectin-1 in C57BL/6 and
BALB/c M and the increased surface expression of dectin-1 in
C57BL/6 cells (Fig. 2D) (12) did not affect the shedding process.
Confirming the specificity of the MR-shedding process, particulate ␤-glucan recognition did not lead to a general release of
receptors from the cell surface, as it failed to induce the shedding of CD44 (Fig. 2E). CD44 can be shed from the cell surface
as a result of multiple signaling pathways by several metalloproteases (19). No band cross-reactive with the anti-MR antibody
was detected in supernatants from MR-KO thio-M treated
with ␤-glucan (Fig. 2F).
␤-Glucan-mediated MR Shedding Requires the Canonical
Signaling Pathway Triggered by Dectin-1 and Is Independent of
TLR—Syk kinase, the kinase responsible for most of dectin-1mediated signaling events, appears to be indispensible for
␤-glucan-induced sMR production because MR shedding was
completely blocked by Syk kinase inhibition (Fig. 3A). Raf-1
kinase seems to be partially responsible for this effect, as
reduced sMR production was observed only at high concentrations of Raf-1 kinase inhibitor (Fig. 3B).
The potential role of the PI3K/Akt (protein kinase B) pathway in ␤-glucan-induced MR shedding was investigated using
PI3K and Akt inhibitors. Phosphoinositides are crucial second
messengers for intracellular signaling pathways initiated by
dectin-1-mediated Syk kinase activation (20 –25). Among several other downstream elements that PI3K activates, Akt was
shown to be required for the production of cytokines such as
IL-12 and IL-10 as well as for controlling cell proliferation and
survival (26 –29). Enhanced MR shedding was completely
blocked upon PI3K inhibition with wortmannin, a potent, cellpermeable, and irreversible inhibitor of PI3K enzymes (Fig. 3C),
but Akt inhibition had no effect (Fig. 3D). Therefore, these
results suggest that ␤-glucan induces MR shedding through an
Akt-independent, PI3K-mediated signaling pathway.
We also investigated if collaboration between dectin-1- and
TLR-mediated signaling could have an effect on the shedding
process by analyzing sMR production in the presence of the
TLR2 agonist Pam3-Cys-Ser-Lys4. TLR2 engagement did not
affect MR shedding in isolation or in combination with ␤-glucan (Fig. 3E), indicating that this process is mediated exclusively by a dectin-1-dependent pathway.
␤-Glucan-induced MR Shedding Is Phagocytosis-independent but Requires Actin Polymerization—Even though dectin-1
is a phagocytic receptor, it does not require phagocytosis to
induce inflammatory responses (30). In fact, dectin-1-mediated
intracellular signaling is enhanced by frustrated phagocytosis
(31, 32). We investigated if phagocytosis is required for dectin1-mediated MR shedding using three different approaches: (i)
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 4. Dectin-1-induced sMR production is phagocytosis-independent but requires actin polymerization. Thio-M were treated with curdlan
and HK C. albicans (A) under serum-free conditions at concentrations of four
particles/cell (10 g of curdlan would contain ⬃550 particles (32)) and 50
particles/cell, respectively. cMR and sMR levels were determined as described
under “Experimental Procedures.” Both particles were found to enhance MR
shedding (A). Latrunculin A inhibited the production of sMR in response to
␤-glucan (␤-Gluc) treatment (B). Higher doses of latrunculin A and cytochalasin D reduced the levels of cMR (C). Data are representative of three independent experiments. Unt, untreated.

FIGURE 3. Dectin-1-mediated MR shedding is dependent on Syk and partially on Raf-1, utilizes the Akt-independent PI3K pathway, and is not
affected by the presence of an agonist for TLR2. Thio-M preincubated for
1 h with Syk kinase inhibitor IV (A), Raf-1 inhibitor I (B), wortmannin (C), or Akt
inhibitor VI (D) were treated with particulate ␤-glucan (␤-Gluc; 50 particles/
cell) for 3 h at 37 °C in the presence of inhibitors. cMR and sMR levels were
assessed in cell lysates and supernatants, respectively, by Western blot analysis as described under “Experimental Procedures.” Thio-M were treated
with Pam3-Cys-Ser-Lys4 (10 g/ml) in the presence or absence of particulate
␤-glucan (50 particles/cell) for 3 h at 37 °C (E). cMR and sMR levels were
assessed in cell lysates and supernatants. Data are representative of three
independent experiments. Unt, untreated.

using the non-phagocytosable ␤-glucan curdlan, (ii) inhibiting
actin polymerization with latrunculin A or cytochalasin D, and
(iii) inhibiting phagosome acidification.
As shown in Fig. 4A, incubation of thio-M with curdlan, a
␤(1–3)-glucan preparation from Alcaligenes faecalis that is
known to be able to hydrate and form gels, enhanced MR shedding, which suggests that dectin-1-mediated MR shedding is
independent of particle internalization. To eliminate the possibility of small curdlan fragments being responsible for the
effects of curdlan effect on MR shedding, only curdlan particles
repeatedly (three times) retained in a 100-m cutoff filter were
used for these experiments. Microscopic examination of these
preparations demonstrated that all small fragments had been
eliminated.
Despite the ability of curdlan to promote MR shedding, we
observed that two inhibitors of actin polymerization that work
through different mechanisms, cytochalasin D (used at 0.5–1
M) and latrunculin A (used at 0.5–5 M), blocked sMR and
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that latrunculin A blocked sMR production in response to
␤-glucan (Fig. 4B). This could be due to an inherent effect of
these inhibitors on MR biology, as a drastic reduction is MR
expression was observed when higher amounts were used: 10
M instead of 5 M for latrunculin and 5 M instead of 1 M for
cytochalasin D (Fig. 4C). In support of phagocytosis not being
required for MR shedding in response to ␤-glucan particles,
inhibition of phagosome acidification using bafilomycin or
chloroquine did not alter sMR production in response to ␤-glucan (data not shown).
Fungus-induced MR Shedding Is Mediated by a Metalloprotease—Comparison of the effects of different protease activity inhibitors on sMR production revealed that MR shedding
under steady-state conditions depends on a metalloproteinase
activity (4). Treatment of thio-M with GM6001, a broad-spectrum matrix metalloproteinase (MMP)/ADAM (a disintegrin
and metalloprotease) inhibitor, blocked HK C. albicans- and
␤-glucan-induced sMR production (Fig. 5, A and C), which suggests that dectin-1-mediated MR shedding, as in the case of
steady-state sMR production, is MMP- or ADAM-dependent.
As expected, GM6001 treatment had a drastic effect on TNF-␣
production (33) but did not affect KC (chemokine CXCL1) production in response to HK C. albicans (Fig. 5B), confirming its
specificity. In this study, we also investigated production of
IL-1␤ and IL-6, which could not be detected (data not shown).
We did not obtain any data supporting a role for MMP-2 or
MMP-9 in MR shedding in response to ␤-glucan using gelatin
zymography; only a band corresponding to MMP-9 was visualized in cell lysates and supernatants from untreated and ␤-glucan- or HK C. albicans-treated thio-M (data not shown).
These observations correlated with quantitative PCR results
demonstrating a lack of MMP-2- and MMP-3-specific mRNAs
VOLUME 286 • NUMBER 10 • MARCH 11, 2011
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FIGURE 5. Dectin-1-induced MR shedding by a non-secreted metalloprotease. GM6001 treatment inhibited MR shedding (A and C). M were treated with
the inhibitor GM6001 (Inh) at 1 h prior and during the 3-h treatment with HK C. albicans (A) or ␤-glucan (␤-Gluc) particles (C), or a GM6001 control (Cont) was
used as a negative control. GM6001 treatment reduced TNF-␣ production but did not affect KC (CXCL1) production in response to HK C. albicans (B). MMP-8and MMP-9-specific mRNAs in thio-M treated with particulate ␤-glucan were quantitated (D). Data are representative of three independent experiments. Unt
and U, untreated.

(data not shown) and the presence of MMP-8- and MMP-9specific mRNAs in thio-M. The levels of MMP-8- and MMP9-specific mRNAs were not affected by the presence of particulate ␤-glucan (Fig. 5D).

DISCUSSION
In this study, we have shown that (i) induction of MR shedding is a broad feature of fungal pathogens such as C. albicans
and A. fumigatus; (ii) ␤-glucan is the cell wall component
responsible for most of the fungus-induced MR shedding; and
(iii) MR shedding in response to ␤-glucan depends completely
on dectin-1, Syk kinase, PI3K, and MMP/ADAM activity, partially on Raf-1 kinase, and is independent of phagocytosis and
Akt.
Induction of MR Shedding Is a Feature of Fungal Pathogens
and Is Mediated by Dectin-1—Enhanced MR shedding was initially described in response to P. carinii (8). Using fixed
A. fumigatus and both HK and fixed C. albicans, we have shown
that MR shedding can also be induced by other opportunistic
pathogens (Fig. 1). In correlation with previous studies demonstrating that dectin-1 is a major pattern recognition receptor
for fungi (34 –36), we showed that fungus-mediated sMR production is induced mainly by ␤-glucan recognition (Figs. 1C
and 2) through dectin-1 (Fig. 2). These results were further
supported by the significant reduction in MR shedding induced
MARCH 11, 2011 • VOLUME 286 • NUMBER 10

by HK C. albicans in dectin-1-deficient cells (Fig. 2B), although
the residual levels observed under these conditions indicate a
potential contribution of other receptors. In agreement with
previous studies demonstrating high dependence on ligand
valence for dectin-1 signaling, soluble ␤-glucan (glucan phosphate), in contrast to particulate ␤-glucan and curdlan, acted as
an antagonist. Further supporting the wide relevance of these
observations, thio-M from C57BL/6 and BALB/c mice shed
equivalent amounts of MR despite the fact that they express
different dectin-1 isoforms (12).
Among the two signaling pathways induced by dectin-1, the
Syk-dependent pathway is the most characterized because of
the common elements shared with other ITAM-mediated
pathways. The Syk-independent signaling pathway is still
poorly characterized but has been shown to involve Raf-1
kinase activity (16). In our study, we showed that the effect of
the Syk-independent pathway on sMR production was significantly weaker than that of the Syk-dependent pathway, whose
inhibition completely stopped the enhanced MR shedding
(Fig. 3).
The partial dependence of the phenomenon on Raf-1 kinase
suggests the requirement of a possible cross-talk between Syk
kinase-dependent and Syk kinase-independent pathways. This
might occur via PI3K because PI3K and Raf-1 kinase were preJOURNAL OF BIOLOGICAL CHEMISTRY
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viously shown to induce activation of each other in response to
various growth factors (37– 40). Apart from PI3K, Raf-1 also
stimulates the downstream kinase MEK, which in turn activates
ERK1/2 (37, 41, 42). Future work will need to address the question as to whether this pathway is required for dectin-1-mediated sMR production. Collaboration between TLR and dectin-1
(17) contributing to MR shedding appears to be unlikely, as
treatment with the TLR2 agonist Pam3-Cys-Ser-Lys4 on its own
or in combination with particulate ␤-glucan (Fig. 3E), even after
prolonged incubation periods (e.g. overnight) (data not shown),
did not influence sMR production.
Role of Actin Polymerization in MR Shedding—The requirement for actin polymerization in this model is intriguing
because this does not appear to be caused by a requirement for
phagosome formation (Fig. 4). A possibility that could explain
these observations is the requirement of actin polymerization
for MR recycling, as suggested by Deslée et al. (43). In this study,
MR-mediated endocytosis of dextran and Der p 1 by human
dendritic cells was shown to be reduced significantly in the
presence of the actin polymerization inhibitor cytochalasin D
(43). This would also explain the drastic reduction in cMR levels observed when actin polymerization inhibitors were used at
higher concentrations (Fig. 4C), as non-recycled MR could be
targeted for degradation. A detailed analysis of MR function in
the absence of actin polymerization would be required to
address this issue.
Enhanced MR Shedding in Response to C. albicans and
␤-Glucan Particles Requires Metalloproteinase Activity—Our
results suggest the requirement for a protease sensitive to the
broad-spectrum metalloproteinase inhibitor GM6001, known
to inhibit both MMPs and ADAM proteins. The lack of soluble
CD44 detection in the ␤-glucan-treated samples (Fig. 2D)
suggests the exclusion of membrane-associated MMP-14,
ADAM-10, and ADAM-17 from the list of candidate enzymes
responsible for the enhanced sMR production, as these metalloproteases have previously been implicated in CD44 ectodomain shedding (19). We attempted to examine further the possible ADAM participation in our model by treating thio-M
with ionomycin, as calcium influx has been shown to activate
selected metalloproteases (33). Treatment of thio-M with
ionomycin had no effect on MR cleavage in the presence of
serum. On the other hand, when ionomycin was added in the
absence of serum, a major increase in sMR production was
detected (data not shown). This could be a consequence of the
increased cell death we observed under these conditions. This
enhanced level of MR ectodomain shedding under conditions
of increased cell death suggested the possibility of the involvement in MR shedding of other ITAM-coupled receptors such as
Mincle, known to recognize dead cells (44). Preliminary results
indicate that uptake of dead cells by thio-M does not affect
MR cleavage, making this possibility unlikely (data not shown).
In an attempt to discern whether the metalloprotease responsible for MR shedding was secreted into the medium, WT
thio-M were incubated with culture supernatants collected
from ␤-glucan-treated MR-deficient M. We reasoned that
this would be a suitable approach because ␤-glucan recognition
is not affected by MR deficiency (19). MR shedding was not
altered upon treatment with culture supernatants collected
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from MR-KO M treated with ␤-glucan (data not shown), indicating that the protease responsible for MR shedding is probably membrane-anchored.
MR and Dectin-1, the Yin and Yang of Fungal Recognition—
MR and dectin-1 bind distinct structures in the fungal cell wall;
MR recognizes the external layer of mannoproteins and mannan, whereas dectin-1 recognizes ␤-glucans. ␤-Glucans are
thought to be largely masked by the mannose-rich outer layer.
This arrangement is considered to facilitate fungal immunoevasion, as ␤-glucans are highly immunogenic and, in isolation
or in combination with other microbial compounds, promote
inflammation. Despite this arrangement of the fungal cell wall,
lack of dectin-1 expression causes defective recognition and
uptake of fungal pathogens by M (45). In vitro studies using
thio-M suggest that MR involvement during C. albicans recognition is restricted to the phagosomal compartment and
leads to enhanced TNF-␣ and MCP-1 production, indicating
that MR can indeed act as a sensor of fungi but, at least in this
experimental model, downstream of dectin-1 (45).
In the mouse model, dectin-1 deficiency leads to increased
susceptibility to fungal infection in the case of P. carinii and
A. fumigatus (34), with conflicting evidence available regarding
its involvement in C. albicans infection (46) and no involvement reported in the case of Cryptococcus neoformans (47). In
the case of MR, one in vivo study suggested that MR deficiency
does not increase susceptibility to C. albicans, and it has been
argued that this could be caused by the use of an intraperitoneal
model of infection (46). Additionally, even though the survival
was similar between WT and MR-KO animals, fungal outgrowth did show a difference. Similarly, in the case of P. carinii,
there was no major effect on survival, but increased inflammatory cells in the bronchoalveolar lavage of MR-KO animals were
observed. Additionally and consistent with a role for MR in
glycoprotein clearance, there was significantly greater glycoprotein accumulation in the lung lavage of MR-KO mice (48).
MR-KO mice were more susceptible to infection by C. neoformans, which appears to correlate with reduced development of
CD4 T cell responses to cryptococcal mannoproteins (2). An
important role of MR in fungal recognition has been suggested
by its ability to bind N-bound mannans from C. albicans, its
involvement in the induction of Th17 responses to C. albicans
(46), and its key role in the recognition of P. carinii by human
alveolar macrophages (49, 50).
MR shedding promoted by dectin-1 could represent an additional mechanism for modulating MR involvement in antifungal responses. sMR is capable of binding fungal particles (5), so
the generation of sMR-coated fungi is a real possibility as indicated by the presence of MR-coated P. carinii in the lungs of
infected animals (8). Additionally, the presence in mice of
ligands for the cysteine-rich domain of MR in cells lacking MR
expression in lymphoid organs (7, 51, 52) and kidneys (53) suggests the possibility of the delivery of MR ligands (both soluble
and particulate) to these organs. Our opinion is that only the
generation of mouse and cellular models in which MR cleavage
does not take place will clarify the contribution of MR shedding
to fungal pathogenesis, particularly in view of the broad effects
that metalloproteinase deficiencies and metalloproteinase
VOLUME 286 • NUMBER 10 • MARCH 11, 2011
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inhibitors have on biological processes at the cellular and organism levels.
In conclusion, we have identified a novel event triggered by
dectin-1 engagement, the enhanced shedding of MR. This
intriguing interplay between two major pattern recognition
receptors involved in fungal recognition has the potential to
bias the innate recognition process and the inflammatory
response to fungi.
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